{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:05:22Z","timestamp":1789473922637,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.endien.2026.501819","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T19:50:34Z","timestamp":1781553034000},"page":"501819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["MEDEA study: Organizational models for the care of type 2 diabetes mellitus in Andalusia \u2014 The endocrinologist\u2019s contribution"],"prefix":"10.1016","volume":"73","author":[{"given":"Pablo Jes\u00fas","family":"Remon-Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rom\u00e1n","family":"Villegas-Portero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Losada Vi\u00f1au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Mangas Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Pumar Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefa","family":"Mayoral S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Mar","family":"Mu\u00f1oz Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Soto Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10027","key":"10.1016\/j.endien.2026.501819_bib0005","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants","volume":"387","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.endien.2026.501819_bib0010","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.medcli.2016.11.022","article-title":"Prevalence of obesity and diabetes in Spanish adults 1987\u20132012","volume":"148","author":"Basterra-Gortari","year":"2017","journal-title":"Med Clin (Barc)"},{"issue":"6","key":"10.1016\/j.endien.2026.501819_bib0015","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.recesp.2013.09.031","article-title":"Prevalence of obesity, diabetes and other cardiovascular risk factors in Andalusia (southern Spain). Comparison with national prevalence data. The Di@bet.es study","volume":"67","author":"Vald\u00e9s","year":"2014","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.endien.2026.501819_bib0020","series-title":"Plan Integral de Diabetes de Andaluc\u00eda. Proceso Asistencial Integrado Diabetes Mellitus","author":"Mart\u00ednez Brocca","year":"2018"},{"issue":"8","key":"10.1016\/j.endien.2026.501819_bib0025","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s11606-014-2855-4","article-title":"Effectiveness and safety of patient activation interventions for adults with type 2 diabetes: systematic review, meta-analysis, and meta-regression","volume":"29","author":"Bolen","year":"2014","journal-title":"J Gen Intern Med"},{"issue":"10","key":"10.1016\/j.endien.2026.501819_bib0030","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.2337\/dc22-2372","article-title":"Care management processes important for high-quality diabetes care","volume":"46","author":"Peterson","year":"2023","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.endien.2026.501819_bib0035","article-title":"Audit and feedback: effects on professional practice","volume":"3","author":"Ivers","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.endien.2026.501819_bib0040","article-title":"Quality improvement strategies for diabetes care: effects on outcomes for adults living with diabetes","volume":"5","author":"Konnyu","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.endien.2026.501819_bib0045","series-title":"Recomendaciones para el uso racional del medicamento en el tratamiento farmacol\u00f3gico de la diabetes mellitus tipo 2 [Internet]","year":"2022"},{"issue":"1 Suppl 1","key":"10.1016\/j.endien.2026.501819_bib0050","first-page":"S181","article-title":"Pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20142025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.endien.2026.501819_bib0055","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s11606-019-05587-2","article-title":"Trends in diabetes management among US adults: 1999\u20132016","volume":"35","author":"Fang","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"3","key":"10.1016\/j.endien.2026.501819_bib0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2023-003377","article-title":"Trends in glycemic, blood pressure, and lipid control in adults with diabetes in Switzerland: the CoLaus|PsyCoLaus Study","volume":"11","author":"Alkandari","year":"2023","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"6","key":"10.1016\/j.endien.2026.501819_bib0065","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/jcpt.12700","article-title":"Cost-effectiveness of multidisciplinary collaborative care versus usual care in the management of high-risk patients with diabetes in Singapore: Short-term results from a randomized controlled trial","volume":"43","author":"Siaw","year":"2018","journal-title":"J Clin Pharm Ther"},{"issue":"7","key":"10.1016\/j.endien.2026.501819_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.107931","article-title":"Non-adherence to antidiabetic and cardiovascular drugs in type 2 diabetes mellitus and its association with renal and cardiovascular outcomes: a narrative review","volume":"35","author":"Denicol\u00f2","year":"2021","journal-title":"J Diabetes Complications"},{"issue":"1","key":"10.1016\/j.endien.2026.501819_bib0075","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s40200-021-00961-6","article-title":"Factors related to barriers and medication adherence in patients with type 2 diabetes mellitus: a cross-sectional study","volume":"21","author":"Zairina","year":"2022","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.endien.2026.501819_bib0080","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12933-024-02365-1","article-title":"Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease","volume":"23","author":"Ritsinger","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"10.1016\/j.endien.2026.501819_bib0085","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s13300-020-00883-1","article-title":"Long-term cost-effectiveness analyses of empagliflozin versus oral semaglutide, in addition to metformin, for the treatment of type 2 diabetes in the UK","volume":"11","author":"Ramos","year":"2020","journal-title":"Diabetes Ther"},{"issue":"10","key":"10.1016\/j.endien.2026.501819_bib0090","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1007\/s12325-023-02612-z","article-title":"Cost-effectiveness of newer antidiabetic drugs as second-line treatment for type 2 diabetes: a systematic review","volume":"40","author":"Zhu","year":"2023","journal-title":"Adv Ther"},{"issue":"698","key":"10.1016\/j.endien.2026.501819_bib0095","doi-asserted-by":"crossref","first-page":"e600","DOI":"10.3399\/bjgp20X712289","article-title":"Primary medical care continuity and patient mortality: a systematic review","volume":"70","author":"Baker","year":"2020","journal-title":"Br J Gen Pract"},{"issue":"5","key":"10.1016\/j.endien.2026.501819_bib0100","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3122\/jabfm.2025.250056R1","article-title":"Primary care physician continuity is a consistent measure associated with lower costs and hospitalizations","volume":"38","author":"Chung","year":"2025","journal-title":"J Am Board Fam Med"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018026001228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018026001228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:39:48Z","timestamp":1789472388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530018026001228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2530018026001228"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2026.501819","relation":{},"ISSN":["2530-0180"],"issn-type":[{"value":"2530-0180","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MEDEA study: Organizational models for the care of type 2 diabetes mellitus in Andalusia \u2014 The endocrinologist\u2019s contribution","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2026.501819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2026.501819","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of SEEN and SED.","name":"copyright","label":"Copyright"}],"article-number":"501819"}}